PRGO News Alert Perrigo Company (PRGO) 166.11 12/25/2014 15:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Perrigo Company (PRGO) 166.11 $PRGO

Stocks Off Highs But Stay Positive; Nike Drags Dow
at Investor's Business Daily - Fri Dec 19, 12:27PM CST
Stocks stayed positive but were off session highs Friday afternoon. The Nasdaq was up 0.2%, while the S&P 500 added 0.1% and the Dow dipped 0.1%. Volume was tracking higher in the stock market today amid quadruple witching of options and futures. The...
PRGO: 166.11 (+1.96), CTAS: 79.86 (+0.22), GILD: 91.29 (+1.84), NKE: 96.29 (+0.32)

Perrigo (PRGO) Is Today's Momo Momentum Stock
at The Street - Fri Dec 19, 8:50AM CST
Trade-Ideas LLC identified Perrigo (PRGO) as a momo momentum candidate
PRGO: 166.11 (+1.96)

Perrigo Set to Possibly Pullback After Yesterday's Rally of 3.50%
Comtex SmarTrend(R) - Wed Dec 17, 4:33PM CST
Perrigo (NASDAQ RGO) traded in a range yesterday that spanned from a low of $154.55 to a high of $159.44. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $156.92 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PRGO: 166.11 (+1.96)

Dividend Contenders: 30 Increases Expected By The End Of February
David Fish - at Seeking Alpha - Sat Dec 13, 1:50PM CST

D: 78.38 (+1.48), MDP: 53.04 (-0.89), ROP: 159.75 (+0.21), LARK: 20.90 (-0.53), PRGO: 166.11 (+1.96), JBHT: 84.91 (-0.02), NU: 55.02 (+1.27), TRI: 40.98 (+0.27), AOS: 56.19 (+0.17), PRE: 114.49 (-0.15), ROL: 33.38 (-0.18), PII: 150.40 (+0.38), CHD: 80.16 (-0.37), TGP: 42.06 (-0.60), GAS: 54.01 (+1.29), LLTC: 46.66 (+0.23), EBTC: 24.47 (-0.20), CMP: 87.48 (+0.37), NEE: 107.98 (+1.66), AVA: 35.84 (+0.66), RHI: 58.91 (+0.05), JKHY: 63.50 (-0.07), ADI: 56.71 (+0.05), CVS: 97.89 (+0.02), ANDE: 55.10 (+0.35), LLL: 128.34 (+0.07), LNT: 67.41 (+1.10)

Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Senior Notes
PR Newswire - Tue Dec 02, 12:31PM CST
Perrigo Company plc ("Perrigo" (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced the closing of the previously announced registered public offering by Perrigo Finance plc, a public limited company incorporated under the laws of Ireland and a finance subsidiary of Perrigo (the "Issuer" , of $1.6 billion Senior Notes consisting of $500 million aggregate principal amount of 3.50% Senior Notes due 2021 (the "2021 Notes" , $700 million aggregate principal amount of 3.90% Senior Notes due 2024 (the "2024 Notes" and $400 million aggregate principal amount of 4.90% Senior Notes due 2044 (the "2044 Notes" and, together with the 2021 Notes and the 2024 Notes, the "Notes" . The Notes will be fully and unconditionally guaranteed on a senior unsecured basis by Perrigo.
PRGO: 166.11 (+1.96)

Perrigo Announces FDA Approval And Launch Of The Generic Version Of Pennsaid® 1.5% w/w
PR Newswire - Tue Dec 02, 7:48AM CST
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for diclofenac sodium topical solution 1.5% w/w. Shipments to our pharmacy customers have commenced.
PRGO: 166.11 (+1.96)

Market Movers - Pharma Industry Stocks - Hospira, Perrigo, Auxilium Pharma, Depomed, and Endo Intl.
PR Newswire - Mon Dec 01, 8:05AM CST
Investor-Edge has initiated coverage on the following equities: Hospira Inc. (NYSE: HSP), Perrigo Company PLC (NYSE: PRGO), Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL), Depomed Inc. (NASDAQ: DEPO), and Endo International PLC (NASDAQ: ENDP). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Friday, November 28, 2014, ended on a mixed note as the Dow Jones Industrial Average finished flat at 17,828.24 and the NASDAQ Composite closed at 4,791.63, up 0.09%. The S&P 500 finished the session 0.25% lower at 2,067.56. During the trading session, seven out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 803.65, up 0.58%, with the index advancing 8.95% in the previous three months. Register for your complimentary reports on these five stocks at:
ENDP: 72.10 (+0.34), PRGO: 166.11 (+1.96), AUXL: 34.40 (+0.18), DEPO: 15.54 (+0.38), HSP: 62.60 (-0.07)

Perrigo Company concludes public offering at USD152.00 per share
M2 - Thu Nov 27, 4:14AM CST
Healthcare company Perrigo Company (NYSE RGO) said on Wednesday that it has closed its public offering of 6,809,210 ordinary shares at a public offering price of USD152.00 per share.
PRGO: 166.11 (+1.96)

After Yesterday's Rally of 1.77% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Nov 26, 4:24PM CST
Perrigo (NASDAQ RGO) traded in a range yesterday that spanned from a low of $156.72 to a high of $159.35. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $158.24 on volume of 738,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PRGO: 166.11 (+1.96)

Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares
PR Newswire - Wed Nov 26, 10:51AM CST
Perrigo Company plc ("Perrigo" (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced the closing of Perrigo's previously announced registered public offering relating to the sale of 6,809,210 ordinary shares at a public offering price of $152.00 per share, including the full exercise of the option to purchase up to an additional 888,157 ordinary shares by J.P. Morgan Securities LLC and Barclays Capital Inc., as representatives of the several underwriters.
PRGO: 166.11 (+1.96)

Perrigo closes debt offering
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 2:56PM CST

PRGO: 166.11 (+1.96)

Perrigo Company's underwriters exercise option to purchase another 888,157 ordinary shares
M2 - Tue Nov 25, 8:44AM CST
Healthcare company Perrigo Company (NYSE RGO) said on Monday that its underwriters have exercised their option, in full, to purchase an additional 888,157 ordinary shares at USD152.00 per share, less the underwriting discount.
PRGO: 166.11 (+1.96)

Perrigo Company intends to issue senior notes in public offering
M2 - Tue Nov 25, 8:39AM CST
Healthcare company Perrigo Company (NYSE RGO) reported on Monday the start of its public offering of three series of senior notes through its finance subsidiary, Perrigo Finance.
PRGO: 166.11 (+1.96)

Perrigo unveils generic Protopic Ointment 0.1% And 0.03% for treating eczema
M2 - Tue Nov 25, 8:34AM CST
Healthcare company Perrigo Company (NYSE RGO) said on Monday that it has launched the authorised generic version of Protopic Ointment 0.1% and 0.03% in the market.
PRGO: 166.11 (+1.96)

Perrigo Company plc Announces The Pricing Of Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance plc
PR Newswire - Mon Nov 24, 3:42PM CST
Perrigo Company plc ("Perrigo" (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced the pricing of the registered public offering by Perrigo Finance plc, a public limited company incorporated under the laws of Ireland and a finance subsidiary of Perrigo (the "Issuer" , of $1.6 billion Senior Notes consisting of $500 million aggregate principal amount of 3.50% Senior Notes due 2021 (the "2021 Notes" , $700 million aggregate principal amount of 3.90% Senior Notes due 2024 (the "2024 Notes" and $400 million aggregate principal amount of 4.90% Senior Notes due 2044 (the "2044 Notes" and, together with the 2021 Notes and the 2024 Notes, the "Notes" . The Notes will be fully and unconditionally guaranteed on a senior unsecured basis by Perrigo. The 2021 Notes were sold at a public offering price of 99.937% of the aggregate principal amount thereof, the 2024 Notes were sold at a public offering price of 99.579% of the aggregate principal amount thereof and the 2044 Notes were sold at a public offering price of 99.701% of the aggregate principal amount thereof.
PRGO: 166.11 (+1.96)

Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Perrigo Is Up 1.3% (PRGO)
Comtex SmarTrend(R) - Mon Nov 24, 9:17AM CST
18 days ago, on November 6th, 2014, Perrigo (NASDAQ RGO) reported its earnings. Analysts, on average, expected earnings of $1.45 per share on sales of $997.9 million. The company actually reported EPS of $1.40 on sales of $951.5 million, missing EPS estimates by $0.05 and missing revenue estimates by $46.4 million. Since the company's report, shares of Perrigo have risen from $152.49 to $154.50, representing a gain of 1.3% in the past 18 days.
PRGO: 166.11 (+1.96)

Perrigo Company plc Announces Underwriters' Full Exercise Of Option To Purchase Ordinary Shares In Connection With The Equity Offering
PR Newswire - Mon Nov 24, 7:48AM CST
Perrigo Company plc ("Perrigo" (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced that the underwriters for Perrigo's previously announced public equity offering of 5,921,053 ordinary shares exercised their option, in full, to purchase an additional 888,157 ordinary shares of Perrigo at $152.00 per share, less the underwriting discount (collectively, the "Equity Offering" .
PRGO: 166.11 (+1.96)

Perrigo Company plc Announces Proposed Public Offering Of Senior Notes Of Its Finance Subsidiary, Perrigo Finance plc
PR Newswire - Mon Nov 24, 7:47AM CST
Perrigo Company plc ("Perrigo" (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced that Perrigo Finance plc, a finance subsidiary of Perrigo incorporated under the laws of Ireland (the "Issuer" , commenced a registered public offering of three series of Senior Notes (collectively, the "Notes" . The Notes will be fully and unconditionally guaranteed on a senior unsecured basis by the Company. The exact terms and timing of the offering will depend upon market conditions and other factors.
PRGO: 166.11 (+1.96)

Comparing The 3 Largest Drug Related Products Companies
Joseph Cafariello - at Seeking Alpha - Mon Nov 24, 6:58AM CST

PRGO: 166.11 (+1.96), AUXL: 34.40 (+0.18), USNA: 103.51 (+0.91)

Perrigo Confirms First to File Patent Challenge for Generic Version of Aveed® (Testosterone Undecanoate) Injection
PR Newswire - Mon Nov 24, 6:54AM CST
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application for testosterone undecanoate injection and that it has notified the owner of the Reference Listed Drug of its filing.
PRGO: 166.11 (+1.96)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

SKE Capitalizes on Halloween Events in London

Updated Category News Views 143

SKE's Bold Step into London's Halloween Vibe Hah! Who would've thought that vaping and Halloween could be a match made in heaven? This year, SKE threw its hat into the ring and wrestled for attention in London’s bustling Halloween music scene. Imagine an entire warehouse pulsing not just with beat-heavy electronic music, but the energy of vaping enthusiasts courtesy of...

Continue Reading
The Melt Grabs Top Spot in Burger Ratings War

Updated Category News Views 94

Burger Battle: The Melt Claims Victory When you're in the cutthroat world of fast-casual dining, grabbing the top spot on any list is no small potatoes. The Melt did just that, snatching the title of America’s Highest-Rated Burger Spot. Based on an in-depth analysis of Google and Yelp reviews, folks have spoken, loud and clear, over the past two years. It's a world...

Continue Reading
iHeartMedia Faces 65% Drop: Fraud Investigation Launched

Updated Category News Views 145

Trouble Tunes for iHeartMedia Investors Alright folks, here's the skinny on iHeartMedia, Inc. These days, it's like everyone's out for a piece of iHeart, and not in the way you'd wanna see—unless you're SBS Law, those shareholder rights hotshots diving into another pond of legal ripples. Seems a heap of head-scratching's going down on their version of transparency with...

Continue Reading
AI Alliance Rethinks Health Plan Engagement

Updated Category News Views 139

Building Bridges in Healthcare Ever seen healthcare stuck in its own muck with disconnected gears attempting to move the same machine? Well, that's precisely the mountain healthplans.ai and URAWARRIOR aim to climb down from. Founders Rachel Spilo and Dr. Bershan Shaw are gearing up to shake hands in their no-nonsense, real-world vow to sync member engagement with the...

Continue Reading
Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 292

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
TCL Unveils Black Friday Steals on Smart Devices

Updated Category News Views 157

TCL's Big Move This Holiday Season When was the last time you saw a deal that actually made you stop and check your wallet? Well, TCL is giving you a reason to dig deep this Black Friday and Cyber Monday. They're slashing prices across smartphones and tablets, trying to elbow their way into your shopping cart with discounts up to $150. Now that's the kind of aggressive...

Continue Reading
OFRM Faces Legal Heat Over Toddler Snack Recall

Updated Category News Views 138

OFRM Under the Microscope: Who Saw This Coming? Smack dab in the middle of navigating everyday market volatility, here's Once Upon A Farm (NYSE: OFRM) taking the spotlight—but for all the wrong reasons. The company got slapped with a stark FDA warning. Their Tractor Wheels toddler snacks allegedly pose a choking risk— think 'dry, sticky mass' refusing to budge with...

Continue Reading
EUBG Faces Tough Third Quarter Amid Challenges

Updated Category News Views 193

What's Happening with EUBG? Entrepreneur Universe Bright Group, better known in the markets as EUBG, is navigating some choppy waters if their recent financial numbers are anything to go by. You'd think companies boasting a digital-focused strategy would be printing money in today's tech-driven world, but EUBG's third quarter of 2026 has a different story to tell. The...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 142

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
A Teen's Opera Encounter Inspires Decades of Passion

Updated Category News Views 94

Unraveling a Lifelong Opera Obsession Back in the dog-eared days of 1970, a teenager waltzed into the Metropolitan Opera and stumbled onto a passion that'd pulse alongside him for over half a century. Now, David E. Lapin rolls out his personal chronicle, 'A Sound Obsession: Fifty-Five Years of Opera at the Met.' Folks, we’re diving into a cultural tapestry that’s...

Continue Reading

Top 5 Most Recently Viewed Articles

RegScale Secures FedRAMP High Authorization: A Game-Changer

Updated Category News Views 263

RegScale Secures FedRAMP High Authorization RegScale, utilizing its innovative Continuous Controls Monitoring platform, has reached the notable milestone of obtaining FedRAMP High Authorization, demonstrating a significant advancement in compliance and risk management within the government sector. This achievement showcases RegScale's commitment to enhancing security...

Continue Reading
SiriusXM Improves Financial Guidance Amid Digital Growth

Updated Category News Views 214

SiriusXM Holdings Inc Experiences Stock Surge SiriusXM Holdings Inc (NASDAQ:SIRI) saw its stock prices climb significantly following the release of its fiscal third-quarter results. Investors responded positively as the company’s future outlook showed promise for expansion. Positive Financial Results The report revealed a subscriber revenue of $1.63 billion for the...

Continue Reading
Explore Top Free AI Image Translators for Your Needs

Updated Category News Views 288

Unlocking the Power of Image Translation Translating text from images is a crucial task in today’s digital world. Whether you need to read signs, understand menus, interpret social media posts, or analyze product reviews, having a reliable image translator can make a significant difference. The right tools not only improve accuracy but also support multiple languages,...

Continue Reading
Exciting Collaboration Unveiled: REESE'S and OREO Join Forces

Updated Category News Views 240

An Exciting New Collaboration The anticipation has been palpable among fans of REESE'S and OREO, and now, the moment has arrived. These iconic brands, celebrated for their unique flavors, are thrilled to present a delectable collaboration that combines their most popular offerings. This partnership responds directly to the enthusiasm and demand expressed by fans....

Continue Reading
Innovative Clinical Research Enhances Care for Cancer Patients

Updated Category News Views 440

Innovative Research at Florida Cancer Specialists Clinical research at Florida Cancer Specialists & Research Institute is making significant strides in expanding treatment options for patients dealing with gastrointestinal and genitourinary cancers. This knowledgeable institute is at the forefront of developing and presenting vital research that contributes to improved...

Continue Reading